logo

For the Inventor, By the Inventor

Planegg, Germany

Ethris Gmbh

USPTO Granted Patents = 28

% Expired Patents = 3.6



Forward Citations = 132

Loading Chart...
Loading Chart...

26 inventors (with patents filed for the assignee):

goldMedal Carsten Rudolph (26 out of 27 patents)

silverMedal Christian Plank (14 out of 15 patents)

bronzeMedal Manish Kumar Aneja (7 out of 7 patents)

4.  Braydon Charles Guild (7 out of 61 patents)

5.  Michael W Heartlein (7 out of 189 patents)

6.  Johannes Geiger (6 out of 6 patents)

7.  Ludwig Weiss (5 out of 6 patents)

8.  Frank DeRosa (5 out of 146 patents)

9.  Lianne Smith (4 out of 13 patents)

10.  Christian Dohmen (4 out of 4 patents)

11.  Johannes-Peter Geiger (4 out of 4 patents)

12.  Mehrije Ferizi (2 out of 2 patents)

13.  Rebekka Kubisch-Dohmen (2 out of 2 patents)

14.  Günther Hasenpusch (2 out of 2 patents)

15.  Frank Derosa (2 out of 28 patents)


Core Competencies:
Ciliopathies
mRNA Delivery
CFTR Compositions
RNA Purification
Cryoprotective Agents
Osteogenesis
Nucleotide Modifications
Active Substance Transfer
Nucleic Acid Introduction
Ligand Conjugates
Translation Efficiency
Polyribonucleotides

28 patents:

1. 12728151 - TREATMENT OF CILIOPATHIES (2026-09-08),
2. 12697301 - Pulmonary Delivery of MRNA to Non-lung Target Cells (2026-08-04),
3. 12594295 - CFTR MRNA COMPOSITIONS AND RELATED METHODS AND USES (2026-04-07),
4. 12522821 - Polyribonucleotide containing deuterated nucleotides (2026-01-13),
5. 12509679 - MRNA PURIFICATION BY TANGENTIAL FLOW FILTRATION (2025-12-30),
6. 12465568 - Cryoprotective agents for particulate formulations (2025-11-11),
7. 12263229 - Induction of osteogenesis by delivering BMP encoding RNA (2025-04-01),
8. 12064484 - Compositions for introducing RNA into cells (2024-08-20),
9. 11981910 - Minimal UTR sequences (2024-05-14),
10. 11510937 - CFTR MRNA compositions and related methods and uses (2022-11-29),
11. 11479768 - ATP-binding cassette family coding polyribonucleotides and formulations thereof (2022-10-25),
12. 11352638 - Minimal UTR sequences (2022-06-07),
13. 11136585 - UTRs increasing the translation efficiency of RNA molecules (2021-10-05),
14. 11104887 - Ornithine transcarbamylase coding polyribonucleotides and formulations thereof (2021-08-31),
15. 11090264 - Pulmonary delivery of mRNA to non-lung target cells (2021-08-17),
Company Overview
Ethris GmbH is a biotechnology company based in Planegg, Germany, specializing in the development of innovative RNA-based therapeutics. The organization focuses on harnessing the potential of messenger RNA (mRNA) technology to create treatments for various diseases, including genetic disorders and infectious diseases. Ethris is committed to advancing the field of RNA medicine through its proprietary platform, aiming to provide effective and safe therapeutic solutions that address unmet medical needs globally.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Ethris Gmbh USPTO Patent Assignee Logo
28 Patents

#4 in Planegg

#1,696 in Germany

#23,299 in the World

Planegg, DE
Planegg, Germany

Ethris Gmbh

Forward Citations = 132

26 inventors:

goldMedal Carsten Rudolph (26 out of 27 patents)

silverMedal Christian Plank (14 out of 15 patents)

bronzeMedal Manish Kumar Aneja (7 out of 7 patents)

4.  Braydon Charles Guild (7 out of 61 patents)

5.  Michael W Heartlein (7 out of 189 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ethris Gmbh. Retrieved from https://idiyas.com/company/ethris

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…